BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11372044)

  • 1. Chemotherapy for advanced non-small cell lung cancer.
    Manegold C
    Semin Oncol; 2001 Apr; 28(2 Suppl 7):1-6. PubMed ID: 11372044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for advanced non-small cell lung cancer: standards.
    Manegold C
    Lung Cancer; 2001 Dec; 34 Suppl 2():S165-70. PubMed ID: 11720760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triplet chemotherapy combinations with new agents: is there a rationale?
    Bunn PA
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
    Perez EA; Gandara DR
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):2-5. PubMed ID: 8209273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal duration of chemotherapy in advanced non-small cell lung cancer.
    Lustberg MB; Edelman MJ
    Curr Treat Options Oncol; 2007 Feb; 8(1):38-46. PubMed ID: 17634834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of MTA in the treatment of non-small cell lung cancer.
    Postmus PE; Green MR
    Semin Oncol; 1999 Feb; 26(1 Suppl 4):31-6. PubMed ID: 10201519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines.
    de Marinis F; Rossi A; Di Maio M; Ricciardi S; Gridelli C;
    Lung Cancer; 2011 Jul; 73(1):1-10. PubMed ID: 21440325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy for lung cancer].
    Fujiwara K; Eguchi K
    Nihon Rinsho; 2000 May; 58(5):1087-92. PubMed ID: 10824554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.
    Belani C;
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):10-4. PubMed ID: 11441409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of stage III non-small cell lung cancer with thoracic radiation therapy and simultaneous platinum chemotherapy.
    Bonomi P
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):101-8. PubMed ID: 8052869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
    Vokes EE
    Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic overview of chemotherapy effects in non-small cell lung cancer.
    Sörenson S; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer.
    Kris MG; Gralla RJ; Martini N; Stampleman LV; Burke MT
    Surg Clin North Am; 1987 Oct; 67(5):1051-9. PubMed ID: 2820069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and prognostic factors of 178 advanced non-small lung cancer patients undergoing different second-line chemotherapeutic regimens].
    Kong Q; Wang XY; Jiang RC; Ba Y; Li K
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):294-9. PubMed ID: 27087377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer.
    Viallet J; Ayoub J; Rousseau P; Souhami L; Hohneker J; Shepherd F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):64-71; discussion 71-2. PubMed ID: 7973771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for advanced non-small cell lung cancer.
    Herbst RS; Dang NH; Skarin AT
    Hematol Oncol Clin North Am; 1997 Jun; 11(3):473-517. PubMed ID: 9209907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy versus single agent chemotherapy in non-small cell lung cancer.
    Cheong K; Spicer J; Chowdhury S; Harper P
    Expert Opin Pharmacother; 2005 Aug; 6(10):1693-700. PubMed ID: 16086655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.